LaPlume Joseph W
SEC CIK 1767215 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CRL | Charles River Laboratories | EVP, Corp Strategy, Develop | 31.0K | $4,364 | $7.89M | 57 | 2021-08-06 | 2026-08-10 |
Most active insiders at CRL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FOSTER JAMES C | Dir | — | $34.84M |
| 2 | Parisotto Shannon M | CEVP, Disc, Safety Assessment | — | $2.97M |
| 3 | Girshick Birgit | COO, Corp. Executive VP | — | $1.82M |
| 4 | Knell Michael Gunnar | SVP, CAO, Fin | — | $1.73M |
| 5 | Creamer Victoria L | EVP, CHRO | — | $1.08M |
| 6 | Andrews Nancy C | Dir | — | $163.4K |
| 7 | LaPlume Joseph W | EVP, Corp Strategy, Develop | $4,364 | — |
| 8 | Mintz Mark | EVP, CIO | — | — |
| 9 | Kemps-Polanco Reshema | Dir | — | — |
| 10 | Barg Steven | Dir | — | — |
Transactions 57
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 16:38 | 2026-08-10 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | G - Gift | $0.00 | -257 | 31.0K | -0.8% | $0 | |
| 2026-06-02 16:40 | 2026-05-29 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | A - Grant | $180.71 | +5,257 | 32.3K | +19% | +$950.0K | |
| M | 2026-06-02 16:40 | 2026-05-30+ | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $180.71 | -979 | 31.3K | -3% | -$176.9K |
| M | 2026-05-28 16:24 | 2026-05-26+ | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $158.76 | -428 | 27.0K | -2% | -$67.9K |
| 2026-03-04 | 2026-03-03 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | P - Purchase | $174.54 | +25 | 27.4K | +0.1% | +$4,364 | |
| 2026-02-03 | 2026-01-30 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | A - Grant | $0.00 | +5,456 | 29.2K | +23% | $0 | |
| 2026-02-03 | 2026-01-30 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $211.68 | -1,749 | 27.4K | -6% | -$370.2K | |
| 2026-01-20 | 2025-08-22 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $163.72 | -400 | 23.7K | -2% | -$65.5K | |
| 2025-08-20 | 2025-08-18 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $157.60 | -800 | 24.1K | -3% | -$126.1K | |
| 2025-08-08 | 2025-08-07 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $150.04 | -400 | 24.9K | -2% | -$60.0K | |
| 2025-06-09 | 2025-06-05 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | G - Gift | $0.00 | -385 | 25.3K | -1% | $0 | |
| 2025-06-03 | 2025-05-31 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $135.63 | -155 | 25.7K | -0.6% | -$21.0K | |
| 2025-06-03 | 2025-05-30 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | A - Grant | $135.63 | +6,709 | 25.9K | +35% | +$909.9K | |
| M | 2025-05-29 | 2025-05-26+ | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $137.17 | -366 | 19.4K | -2% | -$50.2K |
| 2025-05-15 | 2025-05-13 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $145.41 | -500 | 19.5K | -2% | -$72.7K | |
| 2025-02-21 | 2025-02-20 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $162.50 | -4,400 | 20.0K | -18% | -$715.0K | |
| 2025-02-03 | 2025-01-31 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $165.57 | -846 | 24.4K | -3% | -$140.1K | |
| 2025-02-03 | 2025-01-31 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | A - Grant | $0.00 | +2,738 | 25.3K | +12% | $0 | |
| 2024-08-12 | 2024-08-08 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $199.36 | -1,780 | 22.5K | -7% | -$354.9K | |
| 2024-06-04 | 2024-06-03 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | G - Gift | $0.00 | -311 | 24.3K | -1% | $0 | |
| D | 2024-06-03 | 2024-05-31 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | A - Grant | $0.00 | +2,111 | 24.6K | +9% | $0 |
| 2024-05-31 | 2024-05-29 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $214.51 | -223 | 22.5K | -1.0% | -$47.8K | |
| M | 2024-05-28 | 2024-05-26+ | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $217.21 | -552 | 23.0K | -2% | -$119.9K |
| 2024-05-14 | 2024-05-10 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $226.97 | -1,304 | 23.3K | -5% | -$296.0K | |
| A | 2024-03-25 | 2024-01-29 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $220.28 | -994 | 25.4K | -4% | -$219.0K |
| A | 2024-03-25 | 2024-01-29 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | A - Grant | $0.00 | +3,279 | 26.4K | +14% | $0 |
| 2024-02-20 | 2024-02-15 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $238.93 | -838 | 24.6K | -3% | -$200.2K | |
| 2024-01-31 | 2024-01-29 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | A - Grant | $0.00 | +3,350 | 26.5K | +14% | $0 | |
| 2024-01-31 | 2024-01-29 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $220.28 | -1,025 | 25.5K | -4% | -$225.8K | |
| 2023-12-01 | 2023-11-30 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $197.73 | -1,850 | 23.1K | -7% | -$365.8K | |
| DM | 2023-11-13 | 2023-11-09 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale+OE | $173.48 | -9,128 | 25.0K | -27% | -$1.58M |
| D | 2023-11-13 | 2023-11-09 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | M - OptEx | $144.67 | +9,128 | 34.1K | +37% | +$1.32M |
| 2023-08-14 | 2023-08-10 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $216.52 | -700 | 25.0K | -3% | -$151.6K | |
| DM | 2023-05-31 | 2023-05-27+ | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $194.12 | -532 | 25.9K | -2% | -$103.3K |
| D | 2023-05-31 | 2023-05-26 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | A - Grant | $0.00 | +2,189 | 26.2K | +9% | $0 |
| 2023-05-16 | 2023-05-15 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $190.39 | -345 | 24.0K | -1% | -$65.7K | |
| M | 2023-05-15 | 2023-05-12 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $193.03 | -959 | 24.4K | -4% | -$185.1K |
| 2023-02-22 | 2023-02-22 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $243.60 | -317 | 25.3K | -1% | -$77.2K | |
| 2023-01-30 | 2023-01-27 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | A - Grant | $0.00 | +8,676 | 28.9K | +43% | $0 | |
| 2023-01-30 | 2023-01-27 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $244.29 | -3,261 | 25.6K | -11% | -$796.6K | |
| DM | 2022-12-05 | 2022-12-01 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale+OE | $224.25 | -6,409 | 20.2K | -24% | -$1.44M |
| D | 2022-12-05 | 2022-12-01 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | M - OptEx | $109.34 | +6,409 | 26.6K | +32% | +$700.8K |
| 2022-11-07 | 2022-11-04 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $216.36 | -534 | 20.2K | -3% | -$115.5K | |
| 2022-08-08 | 2022-08-05 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $226.13 | -200 | 20.8K | -1.0% | -$45.2K | |
| 2022-08-08 | 2022-07-06 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | G - Gift | $0.00 | -195 | 21.0K | -0.9% | $0 | |
| DM | 2022-05-31 | 2022-05-28+ | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $244.41 | -348 | 21.2K | -2% | -$85.1K |
| D | 2022-05-31 | 2022-05-27 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | A - Grant | $0.00 | +1,657 | 21.5K | +8% | $0 |
| 2022-02-24 | 2022-02-23 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $292.75 | -395 | 19.9K | -2% | -$115.6K | |
| D | 2022-02-23 | 2022-02-14 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | G - Gift | $0.00 | -150 | 21.7K | -0.7% | $0 |
| DM | 2022-02-23 | 2022-02-18+ | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale+OE | $291.55 | -1,539 | 21.3K | -7% | -$448.7K |
| DM | 2022-02-23 | 2022-02-22+ | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $291.60 | -632 | 20.2K | -3% | -$184.3K |
| D | 2022-02-23 | 2022-02-18 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | M - OptEx | $88.05 | +743 | 22.4K | +3% | +$65.4K |
| 2022-02-01 | 2022-01-28 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $312.24 | -4,570 | 21.8K | -17% | -$1.43M | |
| 2022-02-01 | 2022-01-28 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | A - Grant | $0.00 | +11.3K | 26.4K | +75% | $0 | |
| 2021-12-27 | 2021-11-22 | CRL | Charles River Laboratories | EVP, Corp Strategy, Develop | G - Gift | $0.00 | -182 | 8,280 | -2% | $0 | ||
| 2021-12-27 | 2021-12-25 | CRL | Charles River Laboratories | EVP, Corp Strategy, Develop | A - Grant | $0.00 | +6,771 | 15.1K | +82% | $0 | ||
| M | 2021-08-10 | 2021-08-06 | CRL | Charles River Laboratories | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $402.21 | -3,700 | 9,804 | -27% | -$1.49M |
Purchase Sale Sale after option exercise All abbreviations